TRIUMPH-4: 68-Week Results This trial enrolled participants with obesity (BMI 30) and moderate-to-severe knee osteoarthritis
Patients should not use Ozempic if they have personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
We spoke with Seth Kipnis, M.D., a board-certified general surgeon and Medical Director of Bariatric and Robotic Surgery at Jersey Shore University Medical Center, and Ritu Anand, M.D., a board-certified endocrinologist at the Center for Weight Loss at JFK University Medical Center, to explain how bariatric surgery and GLP-1s work, who theyre best for, and what to expect so you can discuss the next right step with your care team
The adverse event report included symptoms such as redness, site swelling, pain, and a red lump at the injection site
& Perry, R
But the clinical pattern is real: patients with MCAS, POTS, dysautonomia, multiple chemical sensitivity, and related conditions who exist in a state of chronic, low-level immune activation that conventional medicine struggles to categorize and largely fails to treat